GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 6:08 PM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $70.66. Bristol-Myers Squibb Co. fell$. 47 or. 8 percent, to $61.99. Hospira fell $1.01 or 1.5 percent, to $65.49.

  • *Apple, P&G, Stryker also see headwinds. NEW YORK, Jan 27- A slew of U.S. multinational companies, from DuPont to Procter& Gamble, showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors, including industrial companies such as 3 M Co,...

  • *Apple also at risk; Microsoft shares plummet on currency concern. NEW YORK, Jan 27- A slew of U.S. multinational companies from DuPont to Microsoft Corp showed that a strong U.S. dollar is hammering their earnings, with several blue chip exporters predicting the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors...

  • Midday Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $70.78. Bristol-Myers Squibb Co. fell$. 61 or 1.0 percent, to $61.85. Hospira fell$. 69 or 1.0 percent, to $65.81.

  • Early Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 10:25 AM ET

    Baxter International Inc. fell$. 27 or. 4 percent, to $70.61. Bristol-Myers Squibb Co. fell$. 81 or 1.3 percent, to $61.65. Hospira fell$. 44 or. 7 percent, to $66.06.

  • Jan 27- Bristol-Myers Squibb Co on Tuesday said profits could fall as much as 16 percent in 2015, a worse forecast than Wall Street had expected, as the stronger dollar takes a toll on U.S. drugmakers. Bristol-Myers, whose shares fell almost 2 percent in premarket trading, said it earned $13 million, or 1 cent per share, in the fourth quarter. Revenue fell 4 percent to...

  • Bristol-Myers quarterly profit beats forecasts Tuesday, 27 Jan 2015 | 7:56 AM ET

    Jan 27- Bristol-Myers Squibb Co reported higher-than-expected quarterly earnings, helped by surprisingly strong sales of its hepatitis C drugs and its Eliquis blood clot preventer. The U.S. drugmaker on Tuesday said it earned $13 million, or 1 cent per share, in the fourth quarter. Revenue fell 4 percent to $4.26 billion, coming in above Wall Street expectations...

  • NEW YORK— Bristol-Myers Squibb Co. barely broke even in the fourth quarter, due to a whopping pension charge and slightly lower prescription drug sales, but the drugmaker easily beat Wall Street's muted profit expectations. Giovanni Caforio, 50, will take over running the company on May 5, the company said last week. The company took a $740 million charge for...

  • Final Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 55 or. 8 percent, to $70.88. Bristol-Myers Squibb Co. rose$. 39 or. 6 percent, to $62.46. Hospira rose $1.11 or 1.7 percent, to $66.50.

  • Midday Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 1:53 PM ET

    Baxter International Inc. fell$. 59 or. 8 percent, to $70.84. Bristol-Myers Squibb Co. rose$. 45 or. 7 percent, to $62.52. Hospira rose$. 42 or. 6 percent, to $65.81.

  • Early Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 12:16 PM ET

    Baxter International Inc. fell$. 58 or. 8 percent, to $70.85. Bristol-Myers Squibb Co. rose$. 06 or. 1 percent, to $62.13. Hospira fell$. 81 or 1.2 percent, to $64.58.

  • Final Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 83 or 1.1 percent, to $71.43. Bristol-Myers Squibb Co. fell$. 02 or percent, to $62.07. Hospira rose$. 65 or 1.0 percent, to $65.39.

  • Midday Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 1:31 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $71.91. Bristol-Myers Squibb Co. rose$. 18 or. 3 percent, to $62.27. Hospira rose$. 50 or. 8 percent, to $65.24.

  • Early Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 11:24 AM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $72.04. Bristol-Myers Squibb Co. rose$. 12 or. 2 percent, to $62.21. Hospira rose$. 23 or. 4 percent, to $64.97.

  • Final Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 6:05 PM ET

    Baxter International Inc. rose$. 90 or 1.3 percent, to $72.26. Bristol-Myers Squibb Co. rose$. 14 or. 2 percent, to $62.09. Hospira rose$. 81 or 1.3 percent, to $64.74.

  • Midday Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 1:29 PM ET

    Baxter International Inc. rose$. 32 or. 4 percent, to $71.68. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $62.06. Pfizer fell$. 16 or. 5 percent, to $32.48.

  • Early Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 12:09 PM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $71.25. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.76. Hospira fell$. 17 or. 3 percent, to $63.76.

  • Final Glance: Pharmaceuticals companies Wednesday, 21 Jan 2015 | 6:01 PM ET

    Baxter International Inc. fell$. 45 or. 6 percent, to $71.36. Bristol-Myers Squibb Co. fell$. 50 or. 8 percent, to $61.95. Hospira rose$. 26 or. 4 percent, to $63.93.

  • Midday Glance: Pharmaceuticals companies Wednesday, 21 Jan 2015 | 1:22 PM ET

    Baxter International Inc. fell$. 33 or. 5 percent, to $71.48. Bristol-Myers Squibb Co. fell$. 28 or. 4 percent, to $62.17. Hospira rose$. 32 or. 5 percent, to $63.99.

  • Early Glance: Pharmaceuticals companies Wednesday, 21 Jan 2015 | 10:45 AM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $71.87. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $62.35. Hospira fell$. 38 or. 6 percent, to $63.29.